The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Johnson & Johnson MedTech has agreed to sell its Acclarent portfolio of ear, nose and throat devices to Integra LifeSciences, which hopes to provide hardware for a range of procedures aimed at the ...
New tools build upon company's minimally-invasive Balloon Sinuplasty™ Platform to improve visualization capabilities during sinus surgery for the treatment of chronic rhinosinusitis. Since 2005, more ...
Pharma marketers may have felt reprieved after a former Warner Chilcott sales chief was acquitted last month. But now, two former Johnson & Johnson execs have been convicted on off-label marketing ...
MENLO PARK, Calif., Jan. 12 Acclarent, Inc., a leadingmedical technology company dedicated to designing, developing andcommercializing devices that address conditions affecting the ear, nose andthroat ...
First cases completed with TruDi Navigation System that allows ENT real-time navigation in the O.R. and surgeon office Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies and a ...
CHEVY CHASE, Md., Dec. 16 New Enterprise Associates, Inc. (NEA), a leading global venture capital firm, today announced that one of its portfolio companies, Acclarent, Inc., has entered into a ...
The settlement comes just days after the former executives who ran Acclarent were convicted of misdemeanor charges related to alleged off-label marketing of sinus balloon catheters. Chris Newmarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results